135 related articles for article (PubMed ID: 11737593)
1. Podocyte injuries exacerbate mesangial proliferative glomerulonephritis.
Morioka Y; Koike H; Ikezumi Y; Ito Y; Oyanagi A; Gejyo F; Shimizu F; Kawachi H
Kidney Int; 2001 Dec; 60(6):2192-204. PubMed ID: 11737593
[TBL] [Abstract][Full Text] [Related]
2. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody.
Wan Y; Gu L; Suzuki K; Karasawa T; Fujioka Y; Han GD; Koike H; Kawachi H; Shimizu F
Nephron Exp Nephrol; 2005; 99(4):e121-9. PubMed ID: 15722645
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
[TBL] [Abstract][Full Text] [Related]
4. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
6. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
7. Mesangial sclerotic change with persistent proteinuria in rats after two consecutive injections of monoclonal antibody 1-22-3.
Kawachi H; Iwanaga T; Toyabe S; Oite T; Shimizu F
Clin Exp Immunol; 1992 Oct; 90(1):129-34. PubMed ID: 1395093
[TBL] [Abstract][Full Text] [Related]
8. Glomerulosclerosis in the rat induced by repeated immune-mediated mesangial cell injury.
Iida H; Izumino K; Asaka M; Entani C; Takata M; Johnson RJ
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):905-12. PubMed ID: 7902884
[TBL] [Abstract][Full Text] [Related]
9. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
Tomita M; Koike H; Han GD; Shimizu F; Kawachi H
Clin Exp Nephrol; 2004 Mar; 8(1):17-26. PubMed ID: 15067512
[TBL] [Abstract][Full Text] [Related]
10. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393
[TBL] [Abstract][Full Text] [Related]
11. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
12. Multi-glycoside of Tripterygium wilfordii Hook. f. reduces proteinuria through improving podocyte slit diaphragm dysfunction in anti-Thy1.1 glomerulonephritis.
Wan YG; Sun W; Zhen YJ; Che XY; Pu HP; Wang Y; Li M; Ruan JG; Yan QJ
J Ethnopharmacol; 2011 Jun; 136(2):322-33. PubMed ID: 21570456
[TBL] [Abstract][Full Text] [Related]
13. [Preventive effect of multi-glycoside of tripterygium Wilfordii Hook. f. on proteinuria and mesangial injury in experimental mesangial proliferative glomerulonephritis].
Wan YG; Sun W; Zhen YJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Sep; 25(9):817-21. PubMed ID: 16248246
[TBL] [Abstract][Full Text] [Related]
14. Glomerular epithelial cell injury accelerates the progression of antibody-induced mesangial proliferative nephritis.
Shinosaki T; Notoya M; Nomura Y; Miyai I; Kobayashi T; Kurihara H
Exp Nephrol; 2002; 10(4):245-58. PubMed ID: 12097828
[TBL] [Abstract][Full Text] [Related]
15. [Suppressive effects of GTW treatment on mesangial lesions in experimental irreversible glomerulosclerosis].
Wan YG; Sun W; Shmizu F; Gu LB; Suziki K; Karasawa T; Kawachi H
Zhongguo Zhong Yao Za Zhi; 2005 Mar; 30(5):361-5. PubMed ID: 15806970
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
[TBL] [Abstract][Full Text] [Related]
17. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
[TBL] [Abstract][Full Text] [Related]
18. An anti-CD5 monoclonal antibody ameliorates proteinuria and glomerular lesions in rat mesangioproliferative glomerulonephritis.
Ikezumi Y; Kawachi H; Toyabe S; Uchiyama M; Shimizu F
Kidney Int; 2000 Jul; 58(1):100-14. PubMed ID: 10886554
[TBL] [Abstract][Full Text] [Related]
19. Long-term observation of glomerulonephritis induced by multiple injections with anti-Thy-1 antibody in rats.
Yagi M; Yamamoto T; Kato S; Nagano N; Kihara I
Pathol Int; 1998 Jul; 48(7):491-8. PubMed ID: 9701010
[TBL] [Abstract][Full Text] [Related]
20. The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis.
Morita Y; Nomura A; Yuzawa Y; Nishikawa K; Hotta N; Shimizu F; Matsuo S
J Am Soc Nephrol; 1997 Sep; 8(9):1363-72. PubMed ID: 9294827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
